Cargando…
Metabolic profiling of Alzheimer's disease brains
Alzheimer's disease (AD) is an irreversible, progressive brain disease and can be definitively diagnosed after death through an examination of senile plaques and neurofibrillary tangles in several brain regions. It is to be expected that changes in the concentration and/or localization of low-m...
Autores principales: | Inoue, Koichi, Tsutsui, Haruhito, Akatsu, Hiroyasu, Hashizume, Yoshio, Matsukawa, Noriyuki, Yamamoto, Takayuki, Toyo'oka, Toshimasa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734482/ https://www.ncbi.nlm.nih.gov/pubmed/23917584 http://dx.doi.org/10.1038/srep02364 |
Ejemplares similares
-
Fukushimura Brain Bank (FBB) -Based in a private geriatric hospital-
por: Akatsu, Hiroyasu, et al.
Publicado: (2012) -
Relationship between dexmedetomidine dose and plasma dexmedetomidine concentration in critically ill infants: a prospective observational cohort study
por: Fujita, Yoshihito, et al.
Publicado: (2017) -
Increase in α-tubulin modifications in the neuronal processes of hippocampal neurons in both kainic acid-induced epileptic seizure and Alzheimer’s disease
por: Vu, Hang Thi, et al.
Publicado: (2017) -
Nasal Extracts from Patients with Alzheimer’s Disease Induce Tau Aggregates in a Cellular Model of Tau Propagation
por: Pahrudin Arrozi, Aslina, et al.
Publicado: (2021) -
A comparison between dosages and plasma concentrations of dexmedetomidine in clinically ill patients: a prospective, observational, cohort study in Japan
por: Fujita, Yoshihito, et al.
Publicado: (2013)